Post

New research · Pathology
Medical sciences (Basel, Switzerland) · 1w
Cohort studyMedical sciences (Basel, Switzerland) · 2026

Prospective Evaluation of CEUS-URM in Axillary Lymph Nodes with Diffuse Cortical Thickening in Breast Cancer Patients.

Roxana Pintican, Calin Schiau, Nicoleta Antone … Patriciu Achimas-Cadariu
Read paper
PathologyCohort study

Contrast-enhanced ultrasound score discriminated metastatic axillary nodes with diffusely thickened cortex

Prospective Evaluation of CEUS-URM in Axillary Lymph Nodes with Diffuse Cortical Thickening in Breast Cancer Patients.

Roxana Pintican … Patriciu Achimas-Cadariu
Medical sciences (Basel, Switzerland) · 2026
Background

Conventional axillary ultrasound (ultrasound) is least reliable in lymph nodes with diffusely thickened cortex.

Methods

This was a prospective single-center study of patients with histologically confirmed breast cancer; one index (most suspicious) node per patient (unit of analysis = index node).

n = 181
Results

Good ability to separate cancer-containing from cancer-free underarm lymph nodes

AUC 0.81 (95% CI 0.68 to 0.92)
null = 00.680.92
CI excludes the null - significant
More results

Within the diagnostically challenging subgroup of lymph nodes with diffusely thickened cortex, conventional axillary ultrasound alone demonstrated limited discriminatory performance for metastatic involvement (AUC 0.43).

CEUS-derived quantitative parameters significantly improved diagnostic accuracy, with the best individual parameter achieving an AUC of 0.68.

More results

At a low threshold, the CEUS score showed high sensitivity (93%), suitable for screening and exclusion of nodal metastases, while at a higher threshold it achieved high specificity (96%), allowing reliable confirmation of metastatic disease.

“
Conclusion · 1 of 2

In this exploratory study, a simple CEUS-URM score improved discrimination of diffusely thickened axillary nodes and may serve as an adjunct to conventional ultrasound.

Conclusion · 2 of 2

The findings are preliminary-derived and tested in the same small cohort-and require external, within-patient paired validation.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
173±230
Vitreous myeloperoxidase levels were higher in patients with more complicated proliferative diabetic retinopathy.
Guideline
at least 20years
patients need this much follow-up because the cancer can come back many years later
Animal / Preclinical
< -7.0 kcal/mol
a lower value means stronger attachment to AMPK/mTOR proteins
Cohort Study
52%
More than half of patients had sudden, severe damage to their liver cells
Cohort Study
15.6%
about 1 in 6 with the deepest submucosal invasion had cancer in nearby lymph nodes
Study
56 recommendations
international experts agreed on guidelines for reporting findings from early cancer samples
Case Report
progression-free survival > 15 months
the cancer did not get worse for more than 15 months
Review
7
the distinct types of slow-growing skin cancers from sweat glands that need careful diagnosis